Formulary guidance and transparency from P&T to point of care

Perspectives on Top Therapy Areas

Posted by Matt Breese on Sep 26, 2017

Find me on:


Many new pharmaceutical treatment options have been introduced to the market this year. Areas such as oncology, anti-rheumatics, and anti-virals are driving growth in the industry. However, oncology remains the top therapeutic area with a worldwide market share of 11.7%. 

The industry has seen momentum from investment in the development of new drugs in these key therapeutic areas. This innovation is also leading to increased prescription drug sales. According to the QuintilesIMS National Prescription Audit database, the total retail sales for prescription drugs filled at pharmacies in the U.S. totaled $379,247,789,544 in the 2016 calendar year.

What are the other top therapy areas this year? Here are the ten areas with the highest worldwide market share according to IGEAHUB

  1. Oncology
  2. Anti-Rheumatics
  3. Anti-virals
  4. Anti-diabetics
  5. Bronchodilators
  6. Vaccines
  7. Anti-hypertensives
  8. Sensory Organs
  9. Anti-coagulants
  10. Immunosuppressants

Pharma's investments in these trending classes impact the entire healthcare network, from payer coverage to physician prescribing and patient utilization. For an in-depth analysis of one particular therapeutic area, view MMIT's Reality Check on Rheumatoid Arthritis. 

Subscribe to the MMIT blog for more pharma, provider, and payer perspectives on key topics that affect the healthcare network.

Subscribe for Weekly Perspectives

Topics: Industry Trends